152 related articles for article (PubMed ID: 37996567)
21. OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors.
Ye GD; Sun GB; Jiao P; Chen C; Liu QF; Huang XL; Zhang R; Cai WY; Li SN; Wu JF; Liu YJ; Wu RS; Xie YY; Chan EC; Liou YC; Li BA
Gastroenterology; 2016 Mar; 150(3):659-671.e16. PubMed ID: 26619963
[TBL] [Abstract][Full Text] [Related]
22. Circulating tumor cells are associated with diffuse spread in stage IV colorectal cancer patients.
Kaifi JT; Kunkel M; Zhu J; Dicker DT; Gusani N; Yang Z; Sarwani NE; Li G; Kimchi ET; Staveley-O'Carroll KF; El-Deiry WS
Cancer Biol Ther; 2013 Dec; 14(12):1174-81. PubMed ID: 24153154
[TBL] [Abstract][Full Text] [Related]
23. GPER Agonist G1 Prevents Wnt-Induced
Abancens M; Harvey BJ; McBryan J
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293473
[TBL] [Abstract][Full Text] [Related]
24. Long noncoding RNA GAS5 inhibits angiogenesis and metastasis of colorectal cancer through the Wnt/β-catenin signaling pathway.
Song J; Shu H; Zhang L; Xiong J
J Cell Biochem; 2019 May; 120(5):6937-6951. PubMed ID: 30672001
[TBL] [Abstract][Full Text] [Related]
25. Wnt/β-catenin signaling regulates Yes-associated protein (YAP) gene expression in colorectal carcinoma cells.
Konsavage WM; Kyler SL; Rennoll SA; Jin G; Yochum GS
J Biol Chem; 2012 Apr; 287(15):11730-9. PubMed ID: 22337891
[TBL] [Abstract][Full Text] [Related]
26. FUBP1 promotes colorectal cancer stemness and metastasis via DVL1-mediated activation of Wnt/β-catenin signaling.
Yin H; Gao T; Xie J; Huang Z; Zhang X; Yang F; Qi W; Yang Z; Zhou T; Gao G; Yang X
Mol Oncol; 2021 Dec; 15(12):3490-3512. PubMed ID: 34288405
[TBL] [Abstract][Full Text] [Related]
27. Aberrant activation of the CD45-Wnt signaling axis promotes stemness and therapy resistance in colorectal cancer cells.
Park SY; Kim JY; Jang GB; Choi JH; Kim JH; Lee CJ; Lee S; Baek JH; Park KK; Kim JM; Chang HJ; Cho NC; Nam JS
Theranostics; 2021; 11(18):8755-8770. PubMed ID: 34522210
[No Abstract] [Full Text] [Related]
28. Sanguisorba officinalis L. suppresses 5-fluorouracil-sensitive and-resistant colorectal cancer growth and metastasis via inhibition of the Wnt/β-catenin pathway.
Zhang W; Peng C; Yan J; Chen P; Jiang C; Sang S; Yuan Y; Hong Y; Yao M
Phytomedicine; 2022 Jan; 94():153844. PubMed ID: 34785413
[TBL] [Abstract][Full Text] [Related]
29. LINC01354 interacting with hnRNP-D contributes to the proliferation and metastasis in colorectal cancer through activating Wnt/β-catenin signaling pathway.
Li J; He M; Xu W; Huang S
J Exp Clin Cancer Res; 2019 Apr; 38(1):161. PubMed ID: 30987669
[TBL] [Abstract][Full Text] [Related]
30. An organoid model of colorectal circulating tumor cells with stem cell features, hybrid EMT state and distinctive therapy response profile.
De Angelis ML; Francescangeli F; Nicolazzo C; Signore M; Giuliani A; Colace L; Boe A; Magri V; Baiocchi M; Ciardi A; Scarola F; Spada M; La Torre F; Gazzaniga P; Biffoni M; De Maria R; Zeuner A
J Exp Clin Cancer Res; 2022 Mar; 41(1):86. PubMed ID: 35260172
[TBL] [Abstract][Full Text] [Related]
31. CDCP1 enhances Wnt signaling in colorectal cancer promoting nuclear localization of β-catenin and E-cadherin.
He Y; Davies CM; Harrington BS; Hellmers L; Sheng Y; Broomfield A; McGann T; Bastick K; Zhong L; Wu A; Maresh G; McChesney S; Yau Wong K; Adams MN; Sullivan RC; Palmer JS; Burke LJ; Ewing AD; Zhang X; Margolin D; Li L; Lourie R; Matsika A; Srinivasan B; McGuckin MA; Lumley JW; Hooper JD
Oncogene; 2020 Jan; 39(1):219-233. PubMed ID: 31471585
[TBL] [Abstract][Full Text] [Related]
32. Activation of WNT/β-catenin signaling results in resistance to a dual PI3K/mTOR inhibitor in colorectal cancer cells harboring PIK3CA mutations.
Park YL; Kim HP; Cho YW; Min DW; Cheon SK; Lim YJ; Song SH; Kim SJ; Han SW; Park KJ; Kim TY
Int J Cancer; 2019 Jan; 144(2):389-401. PubMed ID: 29978469
[TBL] [Abstract][Full Text] [Related]
33. Prognostic value of CD133
Fang C; Fan C; Wang C; Huang Q; Meng W; Yu Y; Yang L; Hu J; Li Y; Mo X; Zhou Z
Cancer Med; 2017 Dec; 6(12):2850-2857. PubMed ID: 29105339
[TBL] [Abstract][Full Text] [Related]
34. Wnt signaling modulator DKK4 inhibits colorectal cancer metastasis through an AKT/Wnt/β-catenin negative feedback pathway.
Liang J; Sun L; Li Y; Liu W; Li D; Chen P; Wang X; Hui J; Zhou J; Liu H; Cao T; Pang M; Guo M; Wang X; Zhao X; Lu Y
J Biol Chem; 2022 Nov; 298(11):102545. PubMed ID: 36181792
[TBL] [Abstract][Full Text] [Related]
35. The Small-Molecule Wnt Inhibitor ICG-001 Efficiently Inhibits Colorectal Cancer Stemness and Metastasis by Suppressing MEIS1 Expression.
Choi JH; Jang TY; Jeon SE; Kim JH; Lee CJ; Yun HJ; Jung JY; Park SY; Nam JS
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948208
[TBL] [Abstract][Full Text] [Related]
36. High Sensitivity of Circulating Tumor Cells Derived from a Colorectal Cancer Patient for Dual Inhibition with AKT and mTOR Inhibitors.
Smit DJ; Cayrefourcq L; Haider MT; Hinz N; Pantel K; Alix-Panabières C; Jücker M
Cells; 2020 Sep; 9(9):. PubMed ID: 32962206
[TBL] [Abstract][Full Text] [Related]
37. A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential.
Fritzmann J; Morkel M; Besser D; Budczies J; Kosel F; Brembeck FH; Stein U; Fichtner I; Schlag PM; Birchmeier W
Gastroenterology; 2009 Jul; 137(1):165-75. PubMed ID: 19328798
[TBL] [Abstract][Full Text] [Related]
38. Highly Correlated Recurrence Prognosis in Patients with Metastatic Colorectal Cancer by Synergistic Consideration of Circulating Tumor Cells/Microemboli and Tumor Markers CEA/CA19-9.
Chu HY; Yang CY; Yeh PH; Hsu CJ; Chang LW; Chan WJ; Lin CP; Lyu YY; Wu WC; Lee CW; Wu JK; Jiang JK; Tseng FG
Cells; 2021 May; 10(5):. PubMed ID: 34068719
[TBL] [Abstract][Full Text] [Related]
39. IWR-1 inhibits epithelial-mesenchymal transition of colorectal cancer cells through suppressing Wnt/β-catenin signaling as well as survivin expression.
Lee SC; Kim OH; Lee SK; Kim SJ
Oncotarget; 2015 Sep; 6(29):27146-59. PubMed ID: 26450645
[TBL] [Abstract][Full Text] [Related]
40. Wnt/β-catenin signaling mediates the suppressive effects of diallyl trisulfide on colorectal cancer stem cells.
Zhang Q; Li XT; Chen Y; Chen JQ; Zhu JY; Meng Y; Wang XQ; Li Y; Geng SS; Xie CF; Wu JS; Zhong CY; Han HY
Cancer Chemother Pharmacol; 2018 Jun; 81(6):969-977. PubMed ID: 29594332
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
